Community lists
Curadoria · Saúde

Lab tools & diagnostics

Por InspectStocksPublished 14 de out. de 202620 companies0 follower

Instruments, supplies and testing services for labs, drugmakers and doctors.

Agrupadas com a ajuda de um modelo de IA e revisadas pelos nossos editores. A linha abaixo de cada empresa diz por que ela está aqui.

Os preços das ações são o fechamento de 11 de nov. de 2026, do feed da bolsa IEX.

Grade mix

A 8B 8C 2D 1F 1

Revenue growing

19 of 20

Free cash flow growing

9 of 20

Median price move, 1 year

+22,0%

  • TMOTHERMO FISHER SCIENTIFIC INC.

    Diagnostics and researchMarket cap US$ 265,9BP/E 37,85

    US$ 717,62+22,5%1Y

    Since added +8,2%

    A+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Acelerando
    Business quality
    Forte
    Getting better
    Melhorando

    Revenue

    US$ 47,4B+8,3%

    Profit

    US$ 7,1B+7,6%

    Free cash flow

    US$ 7,6B+24,3%
    Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
  • DHRDANAHER CORPORATION

    Diagnostics and researchMarket cap US$ 165,5BP/E 38,51

    US$ 235,31+8,0%1Y

    Since added +5,4%

    B+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Acelerando
    Business quality
    Forte
    Getting better
    Melhorando

    Revenue

    US$ 25,6B+5,5%

    Profit

    US$ 4,3B+23,6%

    Free cash flow

    US$ 5,7B+14,2%
    Why it is here: Sells research instruments, supplies and services
  • AAGILENT TECHNOLOGIES, INC.

    Diagnostics and researchMarket cap US$ 49,9BP/E 34,89

    US$ 176,91+17,6%1Y

    Since added +3,1%

    B+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Acelerando
    Business quality
    Forte
    Getting better
    Melhorando

    Revenue

    US$ 7,4B+8,6%

    Profit

    US$ 1,4B+18,0%

    Free cash flow

    US$ 1,3B+16,5%
    Why it is here: Sells lab instruments, consumables and software to labs and drug makers
  • WATWaters Corporation

    Diagnostics and researchMarket cap US$ 46,3BP/E 202,08

    US$ 470,84+21,5%1Y

    Since added +9,7%

    D
    Crescimento e caixa
    Crescendo
    Business trend
    Desacelerando
    Business quality
    Mista
    Getting better
    Misto

    Revenue

    US$ 5,6B+84,2%

    Profit

    US$ 98,6M-84,8%

    Free cash flow

    US$ 290,8M-51,7%
    Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
  • MTDMettler-Toledo International Inc.

    Diagnostics and researchMarket cap US$ 34,8BP/E 37,95

    US$ 1.749,30+20,8%1Y

    Since added +9,4%

    B+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Forte
    Getting better
    Melhorando

    Revenue

    US$ 4,2B+6,5%

    Profit

    US$ 934,1M+11,8%

    Free cash flow

    US$ 870,6M-2,1%
    Why it is here: Makes precision laboratory instruments and weighing equipment
  • ILMNIllumina, Inc.

    Diagnostics and researchMarket cap US$ 32,2BP/E 36,64

    US$ 212,86+74,5%1Y

    Since added -21,5%

    A+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Forte
    Getting better
    Melhorando com força

    Revenue

    US$ 4,5B+5,8%

    Profit

    US$ 895M+27,5%

    Free cash flow

    US$ 1,1B+5,7%
    Why it is here: Sells DNA sequencing instruments and reagents
  • IDXXIDEXX LABORATORIES INC /DE

    Diagnostics and researchMarket cap US$ 55,4BP/E 47,37

    US$ 703,00-1,5%1Y

    Since added +35,2%

    A+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Forte
    Getting better
    Melhorando com força

    Revenue

    US$ 4,7B+11,9%

    Profit

    US$ 1,2B+15,1%

    Free cash flow

    US$ 1,3B+35,3%
    Why it is here: Sells veterinary diagnostic tests and instruments
  • DGXQuest Diagnostics Inc

    Diagnostics and researchMarket cap US$ 28,5BP/E 25,77

    US$ 258,72+40,8%1Y

    Since added +12,2%

    A
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Sólida
    Getting better
    Melhorando

    Revenue

    US$ 11,8B+9,1%

    Profit

    US$ 1,1B+16,5%

    Free cash flow

    US$ 1,4B-1,3%
    Why it is here: Provides diagnostic testing and clinical lab services
  • LHLABCORP HOLDINGS INC.

    Diagnostics and researchMarket cap US$ 30,2BP/E 30,53

    US$ 372,18+41,3%1Y

    Since added +18,7%

    A
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Mista
    Getting better
    Melhorando com força

    Revenue

    US$ 14,6B+6,0%

    Profit

    US$ 1B+17,4%

    Free cash flow

    US$ 1,3B-6,8%
    Why it is here: Provides diagnostic tests and clinical lab services
  • RVTYREVVITY, INC

    Diagnostics and researchMarket cap US$ 17,7BP/E 70,32

    US$ 158,22+68,5%1Y

    Since added +2,0%

    A
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Mista
    Getting better
    Melhorando

    Revenue

    US$ 2,9B+4,6%

    Profit

    US$ 253,2M+6,6%

    Free cash flow

    US$ 590,5M+18,7%
    Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
  • IQVIQVIA HOLDINGS INC.

    Diagnostics and researchMarket cap US$ 45,2BP/E 33,38

    US$ 274,37+24,2%1Y

    Since added +5,2%

    A
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Mista
    Getting better
    Melhorando

    Revenue

    US$ 17,3B+8,8%

    Profit

    US$ 1,4B+8,7%

    Free cash flow

    US$ 2,1B-6,0%
    Why it is here: Runs clinical trials and sells healthcare data to drugmakers
  • NTRANATERA, INC.

    Diagnostics and researchMarket cap US$ 46,4BSem P/L (prejuízo operacional)

    US$ 319,77+52,6%1Y

    Since added -19,2%

    B-
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Fraca
    Getting better
    Misto

    Revenue

    US$ 2,9B+37,4%

    Profit

    -US$ 164,7M+46,7%

    Free cash flow

    US$ 52,5M-50,5%
    Why it is here: Provides genetic and cell-free DNA diagnostic tests
  • TECHBIO-TECHNE Corp

    BiotechnologyMarket cap US$ 11,4BP/E 66,77

    US$ 72,78+19,2%1Y

    Since added +0,4%

    A+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Acelerando
    Business quality
    Forte
    Getting better
    Melhorando com força

    Revenue

    US$ 1,2B+0,9%

    Profit

    US$ 172M+120,5%

    Free cash flow

    US$ 308,2M+37,6%
    Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
  • BRKRBRUKER CORPORATION

    Medical devicesMarket cap US$ 9,5BSem P/L (prejuízo operacional)

    US$ 62,41+47,5%1Y

    Since added +11,0%

    B
    Crescimento e caixa
    Crescendo com força
    Business trend
    Desacelerando
    Business quality
    Mista
    Getting better
    Misto

    Revenue

    US$ 3,5B+2,2%

    Profit

    -US$ 123,4M-490,4%

    Free cash flow

    US$ 244,7M+2.408,5%
    Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
  • RGENREPLIGEN CORP

    Medical instruments and suppliesMarket cap US$ 9,8BNo P/E

    US$ 172,68+9,3%1Y

    Since added -1,6%

    B
    Crescimento e caixa
    Crescendo com força
    Business trend
    Desacelerando
    Business quality
    Mista
    Getting better
    Melhorando

    Revenue

    US$ 805,6M+13,8%

    Profit

    -US$ 11,8M-779,2%

    Free cash flow

    US$ 106,7M-3,0%
    Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
  • BIOBIO-RAD LABORATORIES, INC.

    Medical devicesMarket cap US$ 10,4BSem P/L (prejuízo operacional)

    US$ 386,08+18,0%1Y

    Since added +6,1%

    C
    Crescimento e caixa
    Crescendo
    Business trend
    Estável
    Business quality
    Sólida
    Getting better
    Melhorando

    Revenue

    US$ 2,6B+1,4%

    Profit

    US$ 1B+251,3%

    Free cash flow

    US$ 329,1M-2,3%
    Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
  • QGENQIAGEN N.V.

    Diagnostics and researchMarket cap US$ 10,9BP/E 25,93

    US$ 50,30+19,8%1Y

    Since added +10,7%

    B+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Forte
    Getting better
    Melhorando

    Revenue

    US$ 2,1B+2,1%

    Profit

    US$ 384,5M-5,2%

    Free cash flow

    US$ 436,2M-8,9%
    Why it is here: Supplies sample preparation and molecular testing kits and instruments
  • GHGUARDANT HEALTH, INC.

    Diagnostics and researchMarket cap US$ 20,9BSem P/L (prejuízo operacional)

    US$ 154,76+58,2%1Y

    Since added -4,5%

    B
    Crescimento e caixa
    Crescendo com força
    Business trend
    Estável
    Business quality
    Mista
    Getting better
    Misto

    Revenue

    US$ 1,3B+41,7%

    Profit

    -US$ 485,1M-21,6%

    Free cash flow

    -US$ 232,1M+11,5%
    Why it is here: Provides blood-based cancer diagnostic tests
  • MEDPMedpace Holdings, Inc.

    Diagnostics and researchMarket cap US$ 18,6BP/E 36,90

    US$ 664,52+11,2%1Y

    Since added +9,0%

    C+
    Crescimento e caixa
    Crescendo com força
    Business trend
    Desacelerando
    Business quality
    Forte
    Getting better
    Melhorando com força

    Revenue

    US$ 2,8B+20,4%

    Profit

    US$ 517,8M+19,6%

    Free cash flow

    US$ 667,6M-1,4%
    Why it is here: Runs clinical trials for biotech and pharma drug developers
  • CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.

    Diagnostics and researchMarket cap US$ 16,4BP/E 353,20

    US$ 342,61+99,8%1Y

    Since added +14,5%

    F
    Crescimento e caixa
    Misto
    Business trend
    Encolhendo
    Business quality
    Mista
    Getting better
    Misto

    Revenue

    US$ 4B-1,2%

    Profit

    US$ 40,2M+148,8%

    Free cash flow

    US$ 399,6M-26,5%
    Why it is here: Provides preclinical research models and testing services to drug developers

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.